TY - JOUR
T1 - Serotonergic receptor mechanisms underlying antidepressant-like action in the progesterone withdrawal model of hormonally induced depression in rats
AU - Li, Yan
AU - Raaby, Kasper F.
AU - Sánchez, Connie
AU - Gulinello, Maria
PY - 2013
Y1 - 2013
N2 - Hormonally induced mood disorders such as premenstrual dysphoric disorder (PMDD) are characterized by a range of physical and affective symptoms including anxiety, irritability, anhedonia, social withdrawal and depression. Studies demonstrated rodent models of progesterone withdrawal (PWD) have a high level of constructive and descriptive validity to model hormonally-induced mood disorders in women. Here we evaluate the effects of several classes of antidepressants in PWD female Long-Evans rats using the forced swim test (FST) as a measure of antidepressant activity. The study included fluoxetine, duloxetine, amitriptyline and an investigational multimodal antidepressant, vortioxetine (5-HT3, 5-HT7 and 5-HT1D receptor antagonist; 5-HT1B receptor partial agonist; 5-HT1A receptor agonist; inhibitor of the serotonin transporter (SERT)). After 14 days of administration, amitriptyline and vortioxetine significantly reduced immobility in the FST whereas fluoxetine and duloxetine were ineffective. After 3 injections over 48h, neither fluoxetine nor duloxetine reduced immobility, whereas amitriptyline and vortioxetine significantly reduced FST immobility during PWD. When administered acutely during PWD, the 5-HT1A receptor agonist, flesinoxan, significantly reduced immobility, whereas the 5-HT1A receptor antagonist, WAY-100635, increased immobility. The 5-HT3 receptor antagonist, ondansetron, significantly reduced immobility, whereas the 5-HT3 receptor agonist, SR-57227, increased immobility. The 5-HT7 receptor antagonist, SB-269970, was inactive, although the 5-HT7 receptor agonist, AS-19, significantly increased PWD-induced immobility. None of the compounds investigated (ondansetron, flesinoxan and SB-269970) improved the effect of fluoxetine during PWD. These data indicate that modulation of specific 5-HT receptor subtypes is critical for manipulating FST immobility in this model of hormone-induced depression.
AB - Hormonally induced mood disorders such as premenstrual dysphoric disorder (PMDD) are characterized by a range of physical and affective symptoms including anxiety, irritability, anhedonia, social withdrawal and depression. Studies demonstrated rodent models of progesterone withdrawal (PWD) have a high level of constructive and descriptive validity to model hormonally-induced mood disorders in women. Here we evaluate the effects of several classes of antidepressants in PWD female Long-Evans rats using the forced swim test (FST) as a measure of antidepressant activity. The study included fluoxetine, duloxetine, amitriptyline and an investigational multimodal antidepressant, vortioxetine (5-HT3, 5-HT7 and 5-HT1D receptor antagonist; 5-HT1B receptor partial agonist; 5-HT1A receptor agonist; inhibitor of the serotonin transporter (SERT)). After 14 days of administration, amitriptyline and vortioxetine significantly reduced immobility in the FST whereas fluoxetine and duloxetine were ineffective. After 3 injections over 48h, neither fluoxetine nor duloxetine reduced immobility, whereas amitriptyline and vortioxetine significantly reduced FST immobility during PWD. When administered acutely during PWD, the 5-HT1A receptor agonist, flesinoxan, significantly reduced immobility, whereas the 5-HT1A receptor antagonist, WAY-100635, increased immobility. The 5-HT3 receptor antagonist, ondansetron, significantly reduced immobility, whereas the 5-HT3 receptor agonist, SR-57227, increased immobility. The 5-HT7 receptor antagonist, SB-269970, was inactive, although the 5-HT7 receptor agonist, AS-19, significantly increased PWD-induced immobility. None of the compounds investigated (ondansetron, flesinoxan and SB-269970) improved the effect of fluoxetine during PWD. These data indicate that modulation of specific 5-HT receptor subtypes is critical for manipulating FST immobility in this model of hormone-induced depression.
KW - Flesinoxan
KW - Forced swim test
KW - Ondansetron
KW - Premenstrual dysphoric disorder (PMDD)
KW - Progesterone withdrawal
KW - Vortioxetine
UR - http://www.scopus.com/inward/record.url?scp=84884359677&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884359677&partnerID=8YFLogxK
U2 - 10.1016/j.bbr.2013.09.002
DO - 10.1016/j.bbr.2013.09.002
M3 - Article
C2 - 24016840
AN - SCOPUS:84884359677
SN - 0166-4328
VL - 256
SP - 520
EP - 528
JO - Behavioural Brain Research
JF - Behavioural Brain Research
ER -